MET receptor tyrosine kinase – from neurodevelopment to neurodegeneration

College of Medicine – Phoenix Department of Basic Medical Sciences

When

Noon – 1 p.m., Oct. 23, 2025

WHERE

IN-PERSON: College of Medicine—Phoenix

Health Sciences Education Building (HSEB)

B202 Classroom

 CME INFORMATION & LEARNING OBJECTIVES

CME credit provided by the University of Arizona College of Medicine-Tucson

Learning Objectives

1. Describe the role of MET receptor tyrosine kinase in brain development, including its contribution to neuronal growth,          dendritic spine morphogenesis, and its identification as a genetic risk factor for autism spectrum disorder

2. Explain how alterations in MET signaling pathways contribute to aging and neurodegenerative processes, with emphasis on molecular and cellular mechanisms underlying synaptic vulnerability and circuit dysfunction

3. Discuss the potential protective effects of enhancing MET signaling in neurological conditions, highlighting recent research findings and their translational implications for therapeutic strategies in neurodevelopmental and neurodegenerative          disorders

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing 

Medical Education (ACCME) through the joint providership of The University of Arizona College of Medicine - Tucson and University of Arizona College of Medicine - Phoenix The University of Arizona College of Medicine -Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Arizona College of Medicine - Tucson designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)ä.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Relevant Financial Relationships Statement(s):
University of Arizona College of Medicine - Tucson Continuing Medical Educationadheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Name of individual Individual's role in activity Nature of Relationship(s) / Name of Ineligible Company(s) 

Frederic Zenhausern, MBA Activity Director Nothing to disclose - 02/25/2025 

Shenfeng Qiu, PhD Faculty Nothing to disclose - 10/20/2025 

PRESENTER INFORMATION

 Shenfeng Qiu, PhD

Professor

Department of Basic Medical Sciences

University of Arizona College of Medicine - Phoenix

 

 

 

 

Contacts